Investigating the determinants and dynamics of atherosclerotic plaque instability is a key area of current cardiovascular research. Extracellular matrix degradation from excessive proteolysis induced by enzymes such as cathepsin K (Cat K) is implicated in the pathogenesis of unstable plaques. The current study assessed the expression of Cat K in human unstable atherosclerotic plaques. Specimens of popliteal arteries with atherosclerotic plaques were classified as stable (<40% lipid core plaque area; n=6) or unstable (≥40% lipid core plaque area; n=14) based on histopathological examinations of hematoxylin and eosin stained sections. The expression of Cat K and cystatin C (Cys C) were assessed by immunohistochemical examination and levels of Cat K mRNA were detected by semi-quantitative reverse transcriptase polymerase chain reaction. Morphological changes including a larger lipid core, endothelial proliferation with foam cells and destruction of internal elastic lamina were observed in unstable atherosclerotic plaques. In unstable plaques, the expression of Cat K protein and mRNA was upregulated, whereas Cys C protein expression was downregulated. The interplay between Cat K and Cys C may underlie the progression of plaques from stable to unstable and the current study indicated that Cat K and Cys C are potential targets for preventing and treating vulnerable atherosclerotic plaque ruptures.
Introduction
Atherosclerosis is the principal pathological change that occurs in cardiovascular disease, which is a leading cause of mortality and morbidity worldwide (1) . Rupture of an unstable atherosclerotic plaque, which is characterized by a thinned-out collagen-depleted fibrous cap, a large lipid-rich necrotic core and positive remodeling (2) (3) (4) , is the final event that precipitates coronary thrombosis and occlusion in about two-thirds of cases of sudden cardiac arrest (5) (6) (7) (8) . Understanding the pathophysiology of atherosclerosis and the progression of atherosclerotic plaques from stable to unstable is a key focus of ongoing cardiovascular research (1) . However, the complex molecular and cellular mechanisms that underlie plaque instability are not completely understood, which is a barrier to the development of interventions aimed at treating and preventing plaque instability (9) . Therefore, identifying the mechanisms underlying plaque instability may help to prevent and treat plaque vulnerability.
Plaque instability may be caused by extracellular matrix degradation due to excessive proteolysis (4) . Cysteinyl cathepsins regulate cysteine protease activity in all nucleated cells and maintain a balance between the production and degradation of extracellular matrix. Cystatin C (Cys C) is an important endogenous inhibitor of cathepsins B, H, K, L and S, which may cause the rupture of plaques; cathepsin K (Cat K) is an attractive therapeutic target owing to its collagenase and elastase activity (10) . Selective inhibitors of Cat K, such as Odanacatib, have already been used in phase III clinical trials in patients with osteoporosis (10, 11) It was demonstrated that Cat K knockout reduced plaque formation and complexity in mice (12) . Cat K was the first cathepsin identified in human atherosclerosis over a decade ago (13) . Subsequently, the expression of Cat B, F, L and S in plaques was detected, suggesting that cathepsins have a negative effect on plaque stability.
The increased expression of Cat K in macrophages and vascular smooth muscle cells in the atherosclerotic plaque contrasts with its minimal expression in healthy arteries (13) . In addition, Cat K expression in the endothelium is positively associated with elastic lamina fragmentation, as indicated by immunohistochemical analysis of frozen sections of atherosclerotic human coronary arteries in patients undergoing heart transplant (14) . Increased serum levels of Cat K are closely associated with coronary artery disease (CAD) and circulating Cat K may be a useful biomarker for CAD (15, 16) . However, the expression of Cat K in unstable atherosclerotic plaques in humans and its association with plaque instability remains unknown.
The current study assessed Cat K expression in stable and unstable atherosclerotic plaques sourced from the human popliteal artery to determine the association of Cat K and Cys C expression with plaque instability. The regulatory mechanism for Cat K expression in plaques was investigated to identify potential therapeutic targets.
Materials and methods
Patients and tissue sampling. Between March 2008 and March 2010, 18 patients [14 men (age range, 48-77 years) and 4 women (age range 58-81 years)] with lower extremity arteriosclerosis obliterans undergoing amputation and 10 patients [6 men (age range, 31-42 years) and 4 women (age range, 33-38 years)] undergoing subtotal gastrectomy at the First Hospital of Jilin University (Jilin, China) were enrolled in the current study. All patients in the control group were determined to not exhibit the disease (osteoporosis or rheumatoid arthritis) and were ages between 18 and 85 years old. Popliteal artery specimens with atherosclerotic plaques were collected from the amputated lower extremities. Mesenteric artery specimens without atherosclerotic plaques were sourced from the subtotal gastrectomy specimens. All arterial specimens were washed in phosphate-buffered saline (PBS) and longitudinally sectioned into two halves. One half was immediately frozen and stored at -80˚C prior to RNA extraction; the other half was fixed in 4% paraformaldehyde for 24 h at room temperature prior to hematoxylin and eosin (H&E) staining and immunohistochemical analysis. Sample collections and operations were performed in accordance with the ethical guidelines of the 2013 Declaration of Helsinki and ethical approval for the current study was obtained from the Ethics Committee at Jilin University (Jilin, China). Written informed consent was obtained from all patients prior to their enrollment. H&E staining. Morphological characteristics of the atherosclerotic plaque were detected by H&E staining and plaques were subsequently classified as stable or unstable. Fixed samples were demineralized with 12.5% disodium ethylenediamine tetraacetic acid (EDTA) at room temperature for 1 week and 3-µm thick sections were prepared. H&E-stained sections were observed using a light microscope (BX51; Olympus Corp., Tokyo, Japan) at magnifications of x40, x100 or x400. All examinations were conducted independently by two investigators. Atherosclerotic plaques with a core lipid pool accounting for >40% of the total plaque area were classified as unstable; all other plaques were classified as stable (17) .
Immunohistochemical analyses. The expression of Cat K and Cys C in plaques was determined following immunohistochemical examinations. Antibodies against human Cat K (bs-1611R) were purchased from Beijing Biosynthesis Biotechnology Co., Ltd. (Beijing, China) and those against human Cys C (IT-010-006) were purchased from Abcam (Cambridge, MA, US). Arterial sections that were 3 µm thick were fixed in 5% formaldehyde for 7 days at room temperature and serially dehydrated in successively decreasing concentrations of ethanol (100, 95, 90, 80 and 70%). Following dehydration, sections were attached to poly-l-lysine glass slides, rinsed with PBS (0.01 M, pH 7.4) and treated with hydrogen peroxide to deactivate endogenous peroxides. Sections were blocked for 1 h at room temperature with 1% bovine serum albumin obtained from Beijing Dingguo Changsheng Biotechnology, Co., Ltd. (Beijing, China) in PBS, followed by incubation with the antibodies against Cat K and Cys C (1:100 dilution) for 12 h at 44˚C. Following rinsing in PBS 3 times, specimens were incubated with biotinylated secondary antibody at a dilution of 1:100 (SP9710; Fuzhou Maixin Biotech. Co., Ltd, Fuzhou, China) for 10 min at 37˚C. Specimens were then incubated with horseradish peroxidase conjugated streptavidin solution for 10 min at 37˚C, followed by incubation with diaminobenzidine for 1-2 min at 37˚C. Stained sections were counterstained with H&E and examined under a light microscope at magnifications of x40, x100 and x400. The staining density for Cat K and Cys C immunopositive nuclei and cytoplasm were examined in five randomly selected fields using gray scale analysis (Images Advanced 3.2 systems; Motic Co., Xiamen, China).
Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR).
The expression of Cat K mRNA was measured by semi-quantitative RT-PCR. Total RNA was extracted from plaque tissues using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA), following the manufacturer's instructions. Total RNA was determined by the ratio of optical density readings at 260 and 280 nm and integrity of the specimen was assessed using 1.8% agarose gel electrophoresis. Rat GAPDH, a housekeeping gene, was used as an internal reference. The sequences of the primers used (Sangon Biotech Co., Ltd., Shanghai, China) and parameters of Cat K and GAPDH for amplification are listed in Table I. RT-PCR was performed using the Gene Amplify PCR System (Takara Bio, Inc., Otsu, Japan). Amplification specimens were subjected to electrophoresis on a 1.8% agarose gel (Beijing Dingguo Changsheng Biotechnology, Co., Ltd., Beijing, China), visualized following staining with 0.5 g/ml ethidium bromide (Beijing Dingguo Biotechnology, Co., Ltd.) and images were acquired. An image analysis system (Tanon-4200; Tanon Science & Technology, Co., Ltd., Shanghai, China) was used to scan gel images and the relative intensity of specific PCR bands was determined in relation to GAPDH bands from the same sample.
Statistical analyses. Data were expressed as the mean ± standard deviation. One-way analysis of variance followed by Bonferroni's multiple comparison tests was used to assess between-group differences. Spearman's correlation was used to assess the correlation between the expression of Cat K and Cys C. All statistical analyses were assessed using SPSS 19.0 (IBM Corp., Armonk, NY, USA) and P<0.05 was considered to indicate a statistically significant difference.
Results
Plaque morphology. Six specimens of atherosclerotic tissue were classified as stable plaque and 14 were classified as unstable plaque. Orderly arrangements of endothelial cells and smooth endomembranes were observed in mesenteric artery specimens from controls. No thickening of the media or presence of a lipid core was observed ( Fig. 1A) .
In stable atherosclerotic plaques from popliteal arteries, the proliferation of endothelial cells and internal elastic lamina was detected (Fig. 1B) . In unstable popliteal artery plaques, intimal thickening and the presence of large lipid cores (>40% of the total plaque area) were observed. The proliferation of endothelial cells, presence of foam cells and intimal lipid deposits were also detected. Furthermore, the infiltration of inflammatory cells, presence of cholesterol crystals, destruction of internal elastic lamina along with large lipid deposits and hyperplasia of vascular smooth muscle cells were observed (Fig. 1C ).
Cat K expression in atherosclerotic plaques. Positive brown staining for Cat K was observed in atherosclerotic plaques. In the mesenteric artery specimens from controls, there was weak positive staining for Cat K in the intimal and medial cells ( Fig. 2A ). In the stable popliteal artery plaques, positive staining for Cat K (indicated by the presence of brown particles) was observed in the plaque, intima and media (Fig. 2B ). In the unstable popliteal artery plaques, there was strong positive staining for Cat K in the plaque, intima and media, indicated by the presence of brown flakiness (Fig. 2C) .
Gray scale analyses indicated that the intensity of positive staining for Cat K in stable (161.75±1.38) and unstable (163.9±1.331) plaques was significantly greater than that in normal control mesenteric arteries (120.7±4.18; both P<0.05). Furthermore, the intensity of positive staining for Cat K in unstable plaque specimens was significantly greater than that of stable plaque specimens (P<0.05; Fig. 2D ).
Cat K mRNA expression in unstable atherosclerotic plaques. Levels of Cat K mRNA were significantly upregulated in stable and unstable plaques compared with normal mesenteric artery specimens (both P<0.05). Furthermore, levels of Cat K mRNA in unstable plaques were significantly greater than in stable plaques (P<0.05; Fig. 3 ).
Cys C expression in unstable atherosclerotic plaques. The positive expression of Cys C was indicated by deep brown staining. In the mesenteric arteries from controls, there was positive staining for Cat K in the intimal and medial cells (Fig. 4A) . In stable and unstable atherosclerotic plaques from popliteal arteries, positive staining for Cys C was observed in the plaque, intima and media (brown particles; Fig. 4B and C) .
Grayscale analyses demonstrated that the intensity of positive staining for Cys C in stable (127.20±2.269) and unstable (121.9±1.732) plaque specimens was significantly higher than that in normal mesenteric artery specimens (137.8±3.323; P<0.05 for both). In addition, the intensity of staining in unstable plaque specimens was significantly higher than that of the stable plaque specimens (P<0.05; Fig. 4D ).
The association between the expression of Cat K and Cys C in unstable popliteal artery plaques was assessed using Spearman's correlation analysis. In unstable plaques, an inverse association was observed between the expression of Cat K and Cys C (r=-0.9228, P=0.0011).
Discussion
The current study investigated the association between Cat K and plaque instability in human atherosclerotic plaques. The expression of Cat K mRNA and protein in stable and unstable popliteal artery plaques was greater than that of control mesenteric artery specimens. Furthermore, the expression of Cat K mRNA and protein in unstable plaque was significantly higher than in stable plaques. By contrast, a decrease in the expression of Cys C was detected in stable and unstable plaques and the expression of Cys C in unstable plaques was significantly lower than in stable plaques.
Notably, the decrease in Cys C expression in the atherosclerotic plaques was negatively correlated with an increase in Cat K expression. These results suggest that the elevation of Cat K expression may stimulate the progression of atherosclerotic plaques from stable to unstable. Low expression of Cys C is associated with the high expression of Cat K, therefore Cat K and Cys C may be potential therapeutic targets for preventing and treating unstable atherosclerotic plaques.
Non-ruptured plaques with a large lipid-rich necrotic core and thinned out collagen-depleted fibrous cap, which exhibit smooth muscle cell proliferation, intimal and adventitial inflammation and microcalcification are considered to be unstable or vulnerable plaques, owing to their heightened risk of rupture (4) . The existence of some of these pathological features has been determined in previous clinical studies (18, 19) . Atherosclerotic plaque specimens with a core lipid pool accounting for >40% of the total plaque area is classified as unstable (20) . Furthermore, unstable atherosclerotic plaques exhibit several hallmark features. Such plaques are composed of abundant intimal lipid deposits, proliferating endothelial cells, foam cells, inflammatory infiltrate and cholesterol crystals, and are marked by destruction of internal elastic lamina, large lipid deposits and hyperplasia of vascular smooth muscle cells in the media (20) . All these signs are indicative of unstable atherosclerotic plaques.
In the current study, it was demonstrated that the expression of Cat K mRNA and protein in unstable plaques was significantly higher than in stable plaques. Cat K is a papain-like cysteine peptidase. Its physiological role is reflected in its distinctive cleavage model for type I collagen molecules, which is different from that of the other endogenous collagenases (11) . The specific biological activity of Cat K is to cleave the triple helix of collagen molecules at multiple positions (11) . In addition, Cat K is a powerful elastinolytic enzyme (10,11). Cat K, secreted by macrophages along with several other cysteine cathepsins, degrades the vascular elastic lamina (21) . The involvement of Cat K in macrophage-mediated extracellular elastin degradation (22) and in the degradation of extracellular matrix induced by human macrophage foam cells (23) has been demonstrated. Notably, upregulation of Cat K is also associated with atherosclerosis (13) . In apolipoprotein E-deficient (apoE -/-) mice, a murine model with spontaneous atherosclerosis, Cat K deficiency prevented atherosclerotic plaque progression and the induction of plaque fibrosis (24, 25) . Furthermore, in apoE -/mice, Cat K deficiency is associated with a reduction in the size of atherosclerotic plaques and improved structural integrity of the tunica media, as well as elastic lamina of brachiocephalic arteries (26) . Increased Cat K expression in atherosclerotic plaques (13) and elevated serum levels of Cat K are closely associated with coronary artery disease (15, 16) . These results suggest that the upregulation of Cat K in unstable atherosclerotic plaque may accelerate atherogenesis and induce plaque instability.
The accumulation of oxidized lipids and apoptotic cells in atherosclerotic lesions contributes to plaque rupture and its associated clinical complications (24) . Cys C, a small protein secreted by almost all organs and found in biological fluids, including plasma, is the most plentiful and potent endogenous inhibitor of cathepsins B, H, K, L and S (27) and inhibits the activity of lysosomal cathepsins, such as Cat K. Cys C also serves a regulatory role in autophagy, which protects against the apoptosis induced by 7-oxysterols by preventing lipid accumulation (28) . In addition, it modulates inflammatory responses. These functions are closely associated with apoptosis and plaque destabilization in human atherosclerosis.
In the current study, the elevated expression of Cat K and downregulation of Cys C in unstable plaques was detected. Atherosclerotic mice (apoE -/mice) deficient in Cys C exhibited increased degradation of elastic lamina as well as the formation of larger plaques (29, 30) . Additionally, it was demonstrated that in human atherosclerotic arteries, the expression of Cys C is severely reduced in plaques exhibiting high expression of Cat K (31) . In growing and ruptured abdominal aortic aneurysms, levels of Cat K mRNA, protein and protease activity were elevated, whereas levels of Cys C protein were markedly reduced (32) . Similar alterations in Cat K and Cys C expression were reported in the later stages of cerebral aneurysm progression (33) . Furthermore, the expression of Cys C and Cat K were significantly decreased and increased respectively, during acute myocardial infarction (34) . Additionally, the expression of Cys C was elevated in the brains of Cat K deficient mice (35) . These results indicate that Cat K expression is inversely associated with Cys C expression, which may be inherently associated with atherosclerotic instability.
There were a number of limitations of the current study. Only the expression of Cat K and Cys C were assessed; their activities were not included in the scope of the study. Additionally, the dynamic interplay between Cat K and Cys C in the transformation of atherosclerotic plaques from stable to unstable and the underlying mechanism of action require further clarification. Furthermore, it remains unknown whether inhibiting Cat K and/or activating Cys C are able to attenuate or reverse plaque transformation.
In conclusion, the current study demonstrated that Cat K expression in unstable human popliteal artery plaques was negatively correlated with Cys C expression. The interplay between Cat K and Cys C expression may serve a fundamental role in the progression of plaques from stable to unstable. Therefore, Cat K and Cys C may be potential targets to prevent and treat unstable atherosclerotic plaques. 
